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Introduction: While there is good evidence of the
effectiveness of a variety of interventions and services
to prevent and/or relieve distress experienced by
people affected by cancer, much of this psychosocial
morbidity is undetected and untreated, with
consequent exacerbated suffering, decreased
satisfaction with care, impaired adherence to
treatment regimens and poorer morbidity and
mortality outcomes. The objective of this study is to
develop, implement and assess the impact,
acceptability and cost of an integrated, patient-centred
Psychosocial Assessment, Care and Treatment (PACT)
model of care for patients with urological and head
and neck cancers.
Methods and analysis: A time series research
design will be used to test the PACT model of care,
newly introduced in an Australian tertiary hospital.
The primary outcome is system-level impact,
assessed through audit of patients’ medical records
and Medicare claims for follow-up care. The
secondary outcomes are impact of the model on
patients’ experience and healthcare professionals’
(HCPs) knowledge and confidence, assessed via
patient and HCP surveys at baseline and at follow-
up. Acceptability of the intervention will be assessed
through HCP interviews at follow-up, and cost will
be assessed from Medicare and Pharmaceutical
Benefits Scheme claims information and information
logged pertaining to intervention activities (eg, time
spent by the newly appointed psycho-oncology staff
in direct patient contact, providing training sessions,
engaging in case review) and their associated
costs (eg, salaries, training materials and
videoconferencing).
Ethics and dissemination: Ethics approval was
obtained from the Human Research Ethics
Committees of Hunter New England Local Health
District and the University of NSW.
Results: The results will be widely disseminated to
the funding body and through peer-reviewed
publications, HCP and consumer publications,
oncology conferences and meetings.
Trial registration: The study is registered with the
Australian New Zealand Clinical Trials Registry with
registration number ACTRN12613000916741.
Strengths and limitations of this study
▪ The study has been developed specifically to
address the existing gaps in psychosocial care,
and proposes a model of care which will be inte-
grated, high quality, evidence-based, embedded in
routine practice and responsive to individual
patients’ needs.
▪ It promotes an active role for frontline staff, as well
as improved coordination and continuity of care,
particularly for patients in rural and remote areas.
▪ The lack of research attention on patients with uro-
logical or head and neck cancers, despite their
burden on the Australian community, is addressed.
▪ The translational capacity of the programme is
enhanced through the support of a very strong col-
laborative team, a strong methodology for health
services research (including cost analyses, which
are often overlooked in interventional research)
and a strong support for the integration of psycho-
social care into routine care. Importantly, this work
has a substantial potential for translation into other
cancer services, beyond the current study.
▪ The target population is vulnerable and experiencing
an acute stressor that may impact on recruitment.
▪ As the intervention will continue over a 24-month
period, changes in health professional staff over
that time may be substantial. Consequently, some
of the health professionals who complete a survey
at 24 months may be only minimally exposed to the
intervention and have diluted perceptions of impact.
▪ Other health initiatives may be introduced to hos-
pitals in the study area, which could affect the
impact of this intervention.
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Emotional distress, pain and fatigue are commonly
experienced by the majority of patients with cancer,
while other issues are unique to specific cancer types.
Individuals diagnosed with urological cancers (bladder,
kidney, prostate, testicles, penis) typically experience
urinary and bowel dysfunction and sexual problems.1
Those diagnosed with head and neck (H&N) cancers
(mouth, jaw, throat, larynx, salivary glands, skin of H&N
including melanoma, thyroid) often experience pro-
found disfigurement and functional disability, changed
body image, speech difficulties, nutritional problems
and have higher suicide rates than other people with
cancer.2 Patients with urological and H&N cancer often
report negative changes in their intimate and social rela-
tionships.1 3 Some cancers, including urological and
H&N cancers, are more prevalent in rural areas,4 where
people experience major difficulties accessing cancer
services, including psychosocial care.5 There is good evi-
dence of the effectiveness of a variety of interventions
and services to prevent and/or relieve the distress
experienced by patients with cancer.6 Nevertheless, it is
well established that most of the psychosocial morbid-
ities experienced by patients with cancer are undetected
and untreated.7 Failure to address these problems can
exacerbate suffering and lead to decreased patient satis-
faction with care, impaired adherence to treatment regi-
mens and poorer morbidity and mortality outcomes.8
Recent cancer patient satisfaction surveys in Australia,
the UK and Canada have highlighted the problems in
coordination of services and limitations in psychosocial
care.9–11 Skills, confidence and beliefs of clinical staff
regarding psychosocial aspects of care are important
contributing factors.12 Many healthcare professionals
(HCPs) are not aware of effective evidence-based strat-
egies to address patients’ concerns or underestimate the
benefits of attending to psychosocial needs or referring
to psychosocial personnel or services. There are a few
formalised mechanisms for communication between
healthcare providers and systems of care that may con-
tribute to patients receiving fragmented and poorly
coordinated care, especially those who reside in rural
areas.8 With well-supported stepped care models, the
needs of the majority of patients with cancer can be met
without referral to specialist psychosocial services.13
Models of care that provide basic psychosocial care deliv-
ered by frontline healthcare providers (eg, oncology
nurses), with appropriate training and mentorship by
psycho-oncology specialists, have demonstrated efficacy
and cost-effectiveness in terms of the increase in
quality-adjusted life-years achieved.14
The Institute of Medicine8 has recommended a model
for integrated psychosocial cancer care that comprises:
(1) identifying patients’ health needs through screening
and assessment; (2) linking patients to health services
via structured referral, case management and clinical
integration of services; (3) supporting patients in illness
self-management; (4) coordinating psychosocial and bio-
medical healthcare through care coordinators,
multidisciplinary team meetings, multidisciplinary care
plans and electronic health records and (5) following up
on care delivery by telephone calls or web-based technol-
ogy to re-evaluate and adjust the patient’s care plan.8
Achieving such a model of care in most specialist oncology
services and evaluating its effectiveness represent major
challenges.15 16 These challenges are accentuated in set-
tings where cancer care is integrated into general medical
or surgical care, with the absence of dedicated on-site
cancer teams. This means that staff may not identify them-
selves as cancer clinicians and service models are generic
to cater for a diverse range of illness groups. Nevertheless,
this represents the setting in which a significant propor-
tion of patients with cancer experience at least part of
their treatment. Within this type of care delivery setting,
how can effective models of integrated psycho-oncology
care be developed, implemented and evaluated? This is
one of the key questions this project aims to investigate.
OBJECTIVE
The objective of this study is to develop, implement and
assess the impact, acceptability and cost of an integrated,
patient-centred model for psychosocial screening, care
and treatment of patients with urological and H&N
cancers at a large tertiary referral hospital.
STUDY DESIGN
A time series research design will be utilised to test the
Psychosocial Assessment, Care and Treatment (PACT)
model of care (detailed below). While the RCT is often
used as the gold standard for assessing the effectiveness
of health interventions, it is not always practical in health
services research. A time series design will be used, as it is
regarded as the strongest quasi-experimental design for
evaluating longitudinal effects of interventions17 and is
an acceptable design for inclusion in Cochrane reviews.18
Time series designs attempt to detect whether an inter-
vention has an effect significantly greater than the under-
lying secular trend,18 and are useful in quality
improvement research for evaluating the effects of inter-
ventions when it is difficult to randomise patients. The
study will focus on system-level outcomes as being of
primary interest. We will monitor the process, outcomes
and costs of establishing the specialised psycho-oncology
service, including the development of evidence-based
management protocols and referral pathways specifying
defined roles for different health professionals within the
cancer care setting. Table 1 provides an overview of the
study design and time line.
METHODS
Study setting
The setting for this study is John Hunter Hospital
( JHH)/Royal Newcastle Centre, the largest tertiary
referral teaching hospital in the Hunter New England
Local Health District (HNELHD) of New South Wales
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(NSW), Australia. It provides the main services for a
large sector of the state of NSW, comprising a popula-
tion of over 850 000 people, including a major metropol-
itan centre and several large regional centres, as well as
many smaller rural centres and remote communities.
This area has an average of 4171 new cases of cancer
diagnosed per annum, with over 9000 inpatient separa-
tions per year for cancer-related conditions.19 It is the
main teaching hospital of the University of Newcastle.
The current model of cancer care at JHH, the site for
this study, includes investigation, diagnosis, surgery and
follow-up surveillance. Patients needing radiation or
chemotherapy are referred to a nearby specialist cancer
service and generally return to JHH or a regional hos-
pital facility for follow-up and monitoring. In 2012, 124
urology and 69 H&N patients received inpatient cancer
care at JHH. The JHH urology service comprises five
senior urologists and four dedicated outpatient nursing
staff, and the H&N unit comprises four senior surgeons,
one dedicated outpatient nurse and four ward-based
nurses. Each inpatient unit comprises 20 nursing staff
caring for patients with a range of cancer and non-
cancer conditions. For both tumour groups, multidiscip-
linary team meetings provide a forum to discuss indivi-
duals with complex cancers. Although each unit is
supported by dedicated allied health clinicians, JHH
has no dedicated psycho-oncology services. Patients
requiring psycho-oncology assessment are referred
either to generic Liaison Psychiatry, which provides a
limited role including advice, inpatient consultation
and a restricted level of outpatient assessment, or to the
psycho-oncology service at the nearby cancer hospital,
which is a separate service with no shared records and




Inclusion criteria are: (1) aged 18 years or over, (2) diag-
nosed with a urological cancer or an H&N cancer, and
(3) receiving inpatient and/or outpatient care at JHH.
Patients from metropolitan and all rural areas served by
this hospital are included in the study.
Staff
Staff will be eligible to complete the Knowledge and
Confidence Survey if they: (1) are a nursing or allied
health staff member and (2) provide care for patients
who are receiving inpatient or outpatient urological or
H&N cancer services at this site. Staff will be eligible to
Table 1 Study design and data collection timeline




Recruitment of baseline HCP sample
Completion of Health Professional Knowledge and
Confidence Survey
Recruitment of Patient Cross-sectional Sample #1
Completion of Patient Experience Survey
Retrospective audit of medical and hospital records
for consenting patients
Development and delivery of communication skills
training to health professionals
PACT intervention delivery throughout the study
period
Ongoing monitoring of costs of the intervention (time
spent in direct patient contact, on staff training,
interprofessional case reviews and other




Recruitment of Patient Cross-sectional Sample #2
Completion of Patient Experience Survey




Recruitment of Patient Cross-sectional Sample #3
Completion of Patient Experience Survey
Retrospective audit of medical and hospital records
for consenting patients
Recruitment of postintervention HCP sample
Completion of Health Professional Knowledge and
Confidence Survey
Recruitment and interviews with purposively sampled
HCPs regarding acceptability of the PACT intervention
Retrospective review of Medicare and PBS claims
data for use and costs of medical services and
pharmaceuticals for the three cross-sectional patient
samples (Department of Human Services data
extraction)
Review of hospital’s databases
Assessment of set-up and on-going costs associated
with the PACT intervention
HCP, healthcare professional; PACT, Psychosocial Assessment, Care and Treatment; PBS, Pharmaceutical Benefits Scheme.
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participate in interviews to assess the acceptability of the
PACT care model if they meet the following inclusion
criteria: they (1) are a medical, nursing or allied health
staff member, (2) provide care for patients who are
receiving inpatient or outpatient urological or H&N
cancer services and (3) have been involved in the PACT
care pathway of one or more patients, either on-site at
JHH, or through provision of follow-up care, following
discharge from JHH.
Intervention
It is important to note that this study focuses on a
system-level intervention aimed at modifying provision of
service to all patients attending these units, rather than
recruiting a sample of patients for the provision of a spe-
cific psychosocial intervention. While data are collected
periodically from patients attending this hospital and
from staff, this is chiefly with the intention of examining
the impact of the service changes. The PACT model
focuses on a system of care for patients with H&N or
urological cancers. This model aims to systematise the
approach to screening for distress and responding to
that distress in a coordinated manner, including facilitat-
ing continuity of care for patients who reside some dis-
tance from the acute care setting where they were
treated for cancer. In order to address the needs of
those patients in rural regions, a specific component of
the innovation introduced to the system of care is
extended to this population. The development of this
care model includes the following key components:
1. The implementation for inpatients and outpatients
of the two surgical units of routine screening for dis-
tress, and associated psychosocial care plans.
2. The identification of intervention options for all
levels of need, and pathways to specialist psycho-
oncology care if required.
3. The addition of dedicated psycho-oncology clinical
services (including psychologist, psychiatrist and
mental health nurse).
4. The provision of staff development and support to
implement such a model (including training in
skilled communication to identify and respond to
emotional distress), and structured case review for
complex or challenging cases. The latter strategies
will incorporate oncology clinical staff and others
working with patients with cancer within urban,
regional and remote communities.
5. Videoconferencing to facilitate case review meetings
between clinicians at the hospital base site and those
at rural sites who are engaged in the ongoing post-
discharge care of patients initially treated at the
hospital.
In order to achieve these intervention goals, the fol-
lowing are intrinsic to the service model:
A. A dedicated Clinical Nurse Consultant (CNC), with
experience in psycho-oncology and adult education,
will coordinate the establishment and delivery of the
model, with a special focus on development and
implementation of a systematic and structured
approach to routine screening, triage and manage-
ment of individual physical, psychological and social
concerns during active treatment and at follow-up for
patients with cancer.
B. The CNC, a newly appointed Clinical Psychologist and
two of the investigators with experience in communica-
tion skills training (AG, BK) will develop and deliver a
communication skill-based training programme to
support frontline clinical staff (mostly nursing and
allied HCPs) in implementing the psycho-oncology
care model and facilitating within-team communica-
tion to enhance continuity of patient care. This train-
ing programme will be run on numerous occasions to
reach as many frontline staff as possible during the
intervention period and is based on an evidence-based
consultation skills training programme previously
developed and evaluated by our team.20 21
C. The CNC and Clinical Psychologist will facilitate the
delivery of the care model through the training of
frontline staff, provision of clinical assessment and
specialised evidence-based care for patients who are
referred to the psycho-oncology service, monitoring
of progress on psychosocial care plans including with
rural clinicians through case reviews, and providing
advice as required to rural clinicians to support
linking patients to local rural specialised services.
Where specialised services are not available, the
Clinical Psychologist will collaborate with the local
clinician (eg, rural clinical nurse) to provide out-
reach specialist assessment by videoconference. The
lead psychiatrist (BK) will provide clinical oversight
of the programme, participate in staff training and
direct clinical evaluation and treatment of patients
with the highest level of distress or complexity.
Clinical practice guidelines recommend routine dis-
tress screening of patients with cancer (with feedback to
healthcare providers) at periods of increased vulnerabil-
ity to ensure that those at risk are identified promptly
and offered appropriate treatment.22 As part of the
newly developed model of care, all inpatient and out-
patient patients with urology and H&N cancer will be
screened at their first diagnostic or treatment visit and at
each subsequent follow-up visit, using the distress therm-
ometer (DT) and accompanying Problem Checklist,13
which will inform the development of a care plan to
address the issues identified through the screening and
second-line inquiry. The care plan will facilitate provi-
sion of care tailored to the specific needs of patients
and promote continuity of care across care settings and
providers, including with HCPs in the rural and regional
areas.
The screening and problem checklist will act as a
trigger for frontline staff to inquire about, and discuss
the cause/s of, distress with patients whose distress levels
are above the recommended cut-off of 4 or more out of
10.23 Training for frontline staff will focus on discussing
the cause/s of the distress, developing a psychosocial
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care plan to address identified concerns providing infor-
mation and/or basic counselling, or referring patients
with significant or persistent distress to the
psycho-oncology service and facilitating continuity of
care, including linking patients with hospital and com-
munity services as required. Staff will also assist patients
with access to self-management information on tablets
which will be available during their hospital visit.
Long-term sustainability of these service changes will be
promoted through organisational leadership and man-
agement support, engagement of cancer clinician
leaders in each unit in the design and evaluation of the
service model, and development of a model with the
aim of adaptability and flexibility to diversity of locations
and patient complexity (eg, through complex case
review and revision of psychosocial care plans and active
involvement of clinicians from rural locations in this
process).24
Outcomes
The primary outcome is a system-wide increase in the
proportion of eligible patients receiving care at the study
facility who complete a DT and accompanying Problem
Checklist (see Data Collection Methods) on at least one
occasion and have a psychosocial care plan developed
which complies with recommended care pathways. This
outcome will be assessed at baseline, then at 12 and
24 months postbaseline (ie, following the establishment
of the new model of care—refer to Intervention section).
The secondary outcomes are: (1) an increase in the
proportion of eligible patients receiving care at the study
facility who report positive experiences of their cancer
care at 12 and 24 months postbaseline compared with
patients receiving care in this facility at baseline and (2)
an increase in the proportion of health professionals
providing care to the eligible patient population at the
study facility who report high levels of knowledge and
confidence in responding to patients’ psychosocial con-
cerns at 24 months postbaseline compared with the
health professionals caring for the eligible patient popu-
lation at baseline. HCP satisfaction with the PACT inter-
vention will also be assessed via interviews at follow-up,
and the resource use and costs of the intervention will
be monitored by maintaining comprehensive logs of
intervention activities (eg, time spent by the CNC and
Clinical Psychologist in direct patient contact, providing
training sessions, engaging in case review) and ascribing
the associated costs (eg, CNC and Clinical Psychologist




Three cross-sectional samples of the current inpatients
and outpatients will be recruited, at baseline, 12 and
24 months, to complete a Patient Experience Survey (of
their cancer care) and provide consent for access to their
hospital and other medical records. The main purpose of
these data collection phases is the evaluation of the
impact of system-level changes, rather than recruiting
patients who will undertake the intervention. During the
study audit periods at baseline, 12 and 24 months, the
Research Officer will contact staff of the outpatient
clinics and inpatient wards in which care is provided for
urological and H&N cancers, on a weekly basis, to iden-
tify whether patients meeting the inclusion criteria will
be attending those clinics or wards that week. The
Research Officer will attend those clinics and/or wards at
which the potential participants will be present, briefly
introduce those patients to the study, answer questions
and provide interested persons with an Information Pack.
The Information Pack will contain an Information Letter,
a Consent Form for data to be obtained from HNELHD,
a Consent Form for data to be obtained from the
Department of Human Services, a Request for Summary
of Study Results Form, a copy of the self-administered
Patient Experience Survey and a Paperwork Return
Checklist. Patients will be asked to take the Information
Pack home to consider before completing the survey and
consent forms and posting them back to the researchers,
using a self-addressed reply paid envelope, within 10 days.
Staff at the outpatient clinics and inpatient wards will also
be supplied with Information Packs to distribute to eli-
gible patients who attend the clinic when the Research
Officer is not in attendance.
Staff
Health professional knowledge and confidence survey
Two cross-sectional samples of HCPs involved in the care
of patients with H&N or urological cancers at the study
facility will be recruited during the study audit periods at
baseline and at 24 months, to assess the skills develop-
ment of clinical staff who work at the parent facility. At
each time point, the Research Officer will contact the
Managers of the inpatient wards and outpatient clinics
in which care is provided to patients with urological and
H&N cancers. The Managers will be asked to identify
the nursing and allied health staff members who rou-
tinely provide care to the patients of their respective
wards/clinics, as well as each staff member’s employ-
ment status as either permanent or casual. A list of
HCPs eligible to receive an Information Pack will then
be generated, and Information Packs will be sent via
internal mail to the department at which each staff
member is based. The Information Pack will contain an
Information Letter and a copy of the self-administered
Knowledge and Confidence Survey for HCPs to com-
plete and post back to the researchers, using a self-
addressed reply paid envelope, within 10 days. A second
survey will be mailed to HCPs who do not return a com-
pleted survey within 4–6 weeks and a third survey will be
sent to non-returnees 4–6 weeks after that.
Health professional receptivity and acceptability interviews
At approximately 24 months (nearing study completion),
purposively sampled allied health, nursing and medical
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staff will be interviewed by the Research Officer about the
acceptability of the key aspects of the PACT integrated
model of psychosocial care (including screening, triage,
access to psychosocial services/providers, clinical case
reviews), perceived effectiveness of the model at improv-
ing care and perceived impact of the staff training. The
Research Officer will send an Information Pack to those
staff members who meet the inclusion criteria. The
Information Pack will contain an Information Letter,
Consent Form and Request for Interview Transcript
Form. Consenting staff will participate in a 20 min tele-
phone interview at a mutually convenient time.
Data collection methods
The primary outcome of system-level change will be
assessed through audit of patient medical records and
through Medicare and Pharmaceutical Benefits
Scheme (PBS) claims information for follow-up care
sought via referral through the new model of care; the
secondary outcomes of impact of the model on patient
experiences and on HCP knowledge and confidence will
be assessed via patient and HCP surveys. Acceptability of
the intervention will be assessed via HCP interviews, and
cost of the intervention will be assessed from informa-
tion collected through Medicare and PBS claims infor-
mation, as well as information logged pertaining to
intervention activities (eg, time spent by the CNC and
Clinical Psychologist in direct patient contact, providing
training sessions, engaging in case review) and their
associated costs (eg, CNC and Clinical Psychologist salar-
ies and on-costs, materials used in training sessions,
videoconferencing costs).
Medical records audit and Medicare and PBS claims
information
At baseline, 12 and 24 months, the files of all patients
who provide their consent will be reviewed by the
Research Officer and an appointed research assistant
who is not involved in the intervention delivery, to calcu-
late the proportions of patients (1) who have completed
a DT and accompanying Problem Checklist at least
once, (2) who have had a psychosocial care plan devel-
oped and (3) whose management, including referrals,
complies with recommended care pathways. A checklist
will be used to achieve a systematic approach to extrac-
tion of these records. The coders (Research Officer and
a second research assistant) will initially review one file
with the Clinical Psychologist to ensure consistency in
understanding of the checklist and 10% of the files will
be double-coded by the two coders to calculate inter-
rater reliability.
Medicare and PBS claims information will also be
extracted by the Department of Human Services for
those participants who provide their consent, and will be
reviewed by the health economist investigators (MH and
RV) to extract information relating to psychosocial care
delivered in a hospital or community health setting, by a
private provider, or by a general practitioner.
Patient experience survey
A 35-item survey will include items assessing patient per-
ceptions of care received, relating to the dimensions of
emotional support, information, education and coordin-
ation of care. All items are phrased from the first-person
perspective (eg, “I had confidence and trust in the staff
treating me”), to be answered using a five-point
Likert-type scale ranging from 1=‘strongly disagree’ to
5=‘strongly agree’. A patient experience score will be
aggregated based on the sum of selected responses. The
survey contains three items from the Cancer Care
Survey25 and eight items from the Hospital Care—
Overnight Patient Survey26; all adapted such that they
could be answered from the first-person perspective.
The survey also contains 10 items from the Critical
Cancer Care Events Scale,27 some of which required
adaptation so that they referred to a broader group of
health professionals than doctors, and all of which were
adapted to be answered on a five-point Likert-type scale
(as described above).
The survey will also measure key sociodemographic,
disease and medical variables, including age, residential
location, gender, marital status, indigenous identifica-
tion, languages spoken, country of birth, educational
attainment, employment status, private health coverage,
income, cancer type, date of diagnosis, treatment
received, recurrence status and number of prior
inpatient admissions and outpatient clinic visits.
Health professional knowledge and confidence survey
A 65-item survey will include items targeting health profes-
sionals’ knowledge, skills and confidence pertaining to
responding to patients’ specific psychosocial concerns.
The survey contains 12 items from a Confidence in
Communication Skills and Discussing Prognosis and End-of-Life
Issues module used by Clayton et al.28 The survey also con-
tains a case study and associated Care Planning,
Monitoring and Review items from the Client-Centred
Care—Training Needs Survey29; all adapted such that they
refer to a patient with urological cancer and explicitly
address psychosocial care. A Clinician Belief Scale is con-
tained in the survey; based on the Physician Belief Scale,30
it contains all 32 items of the Physician Belief Scale, but
has been renamed to apply to a broader group of health
professionals than doctors, and items will be answered on
a five-point Likert-type scale ranging from 1=‘strongly dis-
agree’ to 5=‘strongly agree’. Finally, the survey contains the
single-item Clinician Burnout survey, which is the
Physician Burnout survey,31 renamed to apply to a broader
group of health professionals than doctors. A knowledge/
confidence score will be aggregated based on the sum of
selected responses.
The survey will also measure key sociodemographic,
experience and training variables, including age, resi-
dential location, gender, occupational specialty, the
number of years of experience in (1) their current spe-
cialty and (2) in cancer care, the number of hours spent
weekly in direct patient contact, indigenous
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identification, languages spoken, country of birth and
country of training.
Health professional receptivity and acceptability interview
An interview will be scheduled with consenting partici-
pants to assess the acceptability of the key aspects of the
integrated model of psychosocial care (including screen-
ing, triage, access to psychosocial services/providers and
clinical case reviews), perceived effectiveness of the
model in improving care and the perceived impact of
training. It is anticipated that the interview will take
20 min, with an audio recording being made for tran-
scription purposes. An interview schedule previously
developed by our team has been adapted for use in the
present study, and examples of questions in the interview
guide include: “Have you been aware of there being a
more systematic approach to the provision of psychosocial
care for people with H&N or urological cancers over the
past year or so compared with previously?” and “What’s
your impression of patient/family member/caregiver atti-
tudes towards the new model (eg, acceptance)?”
Intervention costs
In keeping with the time series design, information
about resource use and associated costs will be obtained
at baseline, 12 and 24-month time points. Information
will be obtained from the hospital’s databases regarding
emergency department (ED) attendance, triage cat-
egory, whether the patient was admitted or discharged
from the ED and their diagnosis. Information about use
and costs of medical services and pharmaceuticals will
be obtained from Medicare and PBS claims data.
Specific set-up and ongoing costs associated with staff
training, interprofessional case reviews and other com-
munications required to support rural and regional pro-
viders will also be monitored.
Sample size
Patients
Data from the initial 25 patient surveys completed were
used to estimate the required patient sample size. The
mean patient experience score at baseline was rated highly
at 45 of a possible 55. Hence, the research team deter-
mined that a five-point improvement between baseline
and the last follow-up (24 months) would be a meaningful
change, assuming a SD of 7.58 (derived from current
surveys), significance level of 5% and power of 80%, with
at least 38 patients needing to be recruited at each time
point to detect this change over time.
Healthcare professionals
Data from the first 28 surveys completed were used to
estimate the required sample size. The mean score of
knowledge/confidence was moderate at 61.5 of a pos-
sible 105. Hence, it was determined that at least 48
health professionals were required to be recruited at
each time point to achieve a significant improvement of
10 points between baseline and follow-up (24 months),
assuming a SD of 17.13 (derived from current surveys),
significance level of 5% and power of 80%.
Data management
Data which are collected in paper format (ie, patient
consent forms, surveys and requests for study results,
and HCP surveys, requests for study results and interview
transcripts) will be stored in a locked cabinet, accessible
only by the Research Officer. Data which are collected
in computer file format (ie, data obtained through the
Department of Human Services and HNELHD and
interview audio and transcript files) will remain in com-
puter file format. In addition, computer files will be
created for the entry and storage of participant details
and survey responses. All of these electronically stored
data will be maintained in separate, password-protected
files, which will be stored on a password-protected local
area network drive, accessible only by the Research
Officer and the chief investigators. On completion of
data analysis and report writing, computer files will be
transferred to CD-ROM, which will then be stored in a
locked cabinet, accessible only by the Research Officer
and the chief investigators.
Data in paper format will be stored for 7 years, while
computer files will be stored for 15 years. All will be
shredded by a contracted security waste disposal
company at the conclusion of the storage period.
Statistical methods
Analysis of primary and secondary outcomes
This evaluation will focus on the impact and acceptability
of the new model of care, with system-level outcomes
being of primary interest. Cross-sectional data will be col-
lected at baseline, 12 and 24 months on the proportion
of patients (1) who are screened for distress at least once
and (2) who have a psychosocial care plan developed.
Data will be collected at the three time points and ana-
lysed using Poisson or Negative Binomial regression
depending on overdispersion of the counts of each
outcome. The Poisson/Negative binomial models will
include a time variable (0, 12 and 24 months), a before
and after variable, a term for the interaction of these two
variables and an offset variable which is used to adjust for
the total number of patients consented at each time point.
The interaction term will be used to estimate any differ-
ence between the two periods, which would indicate a
slow improvement in the outcome during the intervention
period. The before and after variable will be used to esti-
mate the change in the outcome that may occur immedi-
ately after the introduction of the model of care. The
models will adjust as appropriate for potential confound-
ing variables such as age, gender, residential location, indi-
genous status, cancer type and time since diagnosis.
Patient experience and health professional knowledge and
confidence
For patient experience surveys, a linear regression will
be used to model the patient experience scores over the
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three time points to determine whether there was a sig-
nificant improvement during the study period while
adjusting for potential confounding variables (eg, dur-
ation of care within the service, other psychosocial
support services used, disease and treatment character-
istics, age, and gender). Similarly, for the health profes-
sional knowledge and confidence surveys, a linear
regression will be used to determine whether there was
a difference in the knowledge/confidence scores
between the two time points while adjusting for poten-
tial confounding variables (eg, other training in psycho-
social care received, duration of employment in this
service, prior experience, work role and time allocation,
age, and gender).
Economic analysis
Estimates of resource use and costs will take into
account the costs of implementation of the new model,
but will not include costs of the evaluation/audit. At
each time point (baseline, 12 and 24 months), mean
estimates of costs will be used and CIs will be generated
by boot-strapping the data. Benefits will be measured via
surveys and interviews to ascertain the acceptability of
the intervention and how the new model is experienced,
as well as changes in clinicians’ knowledge and confi-
dence. Costs and outcomes will be reported separately at
each time point and trends over time will be evaluated.
Qualitative analysis of HCP interviews
HCP interviews will be audiorecorded, transcribed verba-
tim and analysed qualitatively. Inductive thematic ana-
lysis will be used to identify, analyse and report themes
(or patterns) in the data (MapInfo Professional V.8,
MapInfo Corporation). Transcripts will be initially read
and any words, statements and/or paragraphs related to
HCPs’ views on the PACT intervention will be extracted
by assigning a label or code. Similar excerpts will be
identified by using the same code, with clustering of the
codes denoting themes in the data. Data analysis will
focus on a detailed description of emerging themes,
with a focus on identifying the positive and negative
aspects of the PACT model and strategies to support its
ongoing implementation in the care facility.
DISCUSSION
This research programme specifically addresses the
objective of improving quality of care of patients with
cancer and has been developed to address the existing
gaps in psychosocial care. The proposed programme will
provide a mechanism for delivering integrated, high
quality, evidence-based cancer care that is embedded in
routine practice, and responsive to the needs of individ-
ual patients with cancer by (1) systematically identifying
patients’ physical and psychosocial health needs, (2)
developing care pathways and plans to address identified
needs, (3) linking patients to skilled HCPs and appropri-
ate services and (4) coordinating ongoing psychosocial
healthcare. The project has a focus on translating evi-
dence regarding psychosocial care into an integrated
model that promotes the role of ‘frontline’ clinical staff,
including those in rural settings, and will promote
improved coordination and continuity of care for
patients in rural and remote areas. Improving the psy-
chosocial component of routine care, building distress
screening into a model of routine care and developing a
psychosocial care plan for patients will enhance the
acceptability and appropriateness of psychosocial care.
Specialist services will be active in providing training,
advice and support within an interprofessional team,
and providing specialist assessment and treatment as a
member of this team when needed. Addressing the
process and outcome variables will support investigation
of the quality of care provided from the patient’s and
clinician’s perspectives.
The proposed care model has the potential to address
several unmet needs identified in key policy documents
and surveys. Specifically, it will provide improved emo-
tional support and information for cancer inpatients and
outpatients,9 expand psycho-oncology services to improve
access to specialised care19 and provide timely individua-
lised support to the level and detail required for patients.32
In addition, this research programme directly addresses
the priority issue of delivering quality cancer care that
addresses patients’ physical and psychosocial health
needs 6 8 by bringing together the scientific evidence
about the management of psychosocial problems of
patients with cancer into a model of patient-centred
cancer care. Furthermore, it focuses on patients with uro-
logical or H&N cancers given their lack of research atten-
tion compared with their burden on the Australian
community.33
The translational capacity of this research programme
is enhanced through three major strengths. First, it is
supported by a very strong collaborative team.
Enhancing the role of ‘frontline’ clinical staff, defining
pathways of care and promoting integration between
major centres and rural clinicians entail a high level of
support from clinical staff for objective implementation
and evaluation. This project has a strong support from
the highest level of cancer service governance in our
area, senior nursing clinicians and existing on-site psy-
chiatric services. The linkage of the PACT model to area-
level network of psycho-oncology services will promote
integration of psychosocial care into routine clinical
care, promote continuity of care and, through its clin-
ician training model, improve the overall quality of care
for patients and their families.
Second, the study utilises a strong methodology appro-
priate for health services research. The evaluation frame-
work and methodology ensure that the evaluation is
sensitive to the role of general clinical staff, appropriate
to the setting, relevant to stakeholders, inclusive and
informative. Cost analyses will be undertaken to facilitate
comparisons of costs and outcomes and changes in these
over time; an important consideration as economics is an
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often overlooked element of interventional research. The
close engagement of clinicians in the planning, imple-
mentation and evaluation will ensure a maximum rele-
vance of the project to the local context of clinical
practice, including rural and remote settings. The
built-in capacity for flexibility in the clinical setting (eg,
documenting and addressing local barriers to integration
of psychosocial care) will promote translation to routine
care, and potential applicability to other settings.34
Third, there is a strong support for integration of psy-
chosocial care into routine care, and efficient use of spe-
cialist services. This project will provide important
evidence for the effective use of existing resources for
nurses and allied health professionals working in routine
cancer care. If the outcomes of the research are positive,
this will provide the basis for a model of implementing
psycho-oncology services across other clinical services
within this network. While the project includes the use of
routine screening, it does so in a manner that builds this
into a model of care, so that these tools can support clin-
ical practice within a model of integrated care, defined
service pathways and support to distant sites. The work
has substantial potential for translation into other cancer
services beyond the research collaborators.
Despite the strengths, there are also several challenges
for the research and evaluation. The target population is
vulnerable and experiencing an acute stressor that may
impact on recruitment. As the intervention will continue
over a 24-month period, changes in health professional
staff over that time may be substantial. Hence, some of
the health professionals completing the survey at
24 months may have been minimally exposed to the
intervention, hence potentially diluting the perceptions
of impact. Finally, health initiatives introduced more
broadly into hospitals in the study location may affect
the impact of this intervention, but are beyond the
control of the research team.
ETHICS AND DISSEMINATION
Minor adverse events (eg, a participant being tearful
and distressed when talking with the Research Officer)
will be logged and fed back to the study team by the
end of the study. Serious adverse events (eg, expressing
suicidal thoughts) will be reported immediately to the
chief investigators and to the ethics committees. Any
protocol amendments will be submitted to the ethics
committees before these are implemented, and relevant
changes will also be communicated to other relevant
organisations (eg, trial registry).
Confidentiality
The names of potential patient and HCP participants will
be entered into the study’s password-protected adminis-
trative database, accessible only by the Research Officer.
On receipt of completed surveys and/or consent forms
from participants, a study ID will be assigned to each par-
ticipant, and recorded with identifying information only
in the study’s password-protected administrative database.
Thereafter, survey, consent form and request for results
data will be linked to participants only via the allocated
study ID. There is no foreseeable reason for personal or
identifying participant information to be shared through-
out the conduct of the trial, except where required for
adverse event reporting.
All of the electronically stored personal participant
information will be maintained and destroyed in the
same manner as for all data collected throughout the
study. On completion of data analysis and report writing,
computer files will be transferred to CD-ROM, which will
then be stored in a locked cabinet, accessible only by the
Research Officer. These will be stored for 15 years, then
shredded by a contracted security waste disposal
company at the conclusion of the storage period.
Access to data
The study’s chief investigators (AG and BK), Research
Officer, Biostatistician and Health Economists will have
exclusive access to the final trial dataset.
Dissemination policy
The results will be widely disseminated through peer-
reviewed publications as well as relevant HCP and con-
sumer publications. Oncology HCPs and administrators
within HNELHD will be invited to a face-to-face presenta-
tion of the results by the chief investigators. Presentations
will be delivered at relevant national oncology and
nursing conferences and meetings. The results will be
reported to the funding body and other peak bodies with
influence on cancer policy and practice, including
Cancer Australia, Clinical Oncology Society of Australia,
Cancer Council Australia and Cancer Voices Australia. In
addition, a copy of the summary of the study’s key find-
ings will be mailed to all research participants who
request one, on completion of the project.
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